These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4848139)

  • 1. [Biopharmacy. Note IV. Influence of the technologic process and bile salts on the biopharmaceutic parameters in vitro of flufenamic acid in tablets].
    Arias I; Cadorniga R
    Boll Chim Farm; 1974 Feb; 113(2):82-90. PubMed ID: 4848139
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biopharmacy. 3. Influence of solvents and agglutinins on the biopharmaceutic parameters in vitro of flufenamic acid in tablets].
    Arias I; Cadorniga R
    Boll Chim Farm; 1973 Dec; 112(12):804-12. PubMed ID: 4793201
    [No Abstract]   [Full Text] [Related]  

  • 3. [Biopharmaceutics. II. Methods of determination and criteria for expression of dissolution velocity].
    Cadorniga R; Arias I
    Boll Chim Farm; 1973 Oct; 112(10):635-44. PubMed ID: 4782259
    [No Abstract]   [Full Text] [Related]  

  • 4. [Development of hardness and solution rate of tablets as a function of the compression force].
    Delonca H; Puech A; Youakim J; Segura G
    J Pharm Belg; 1967; 22(5):209-12. PubMed ID: 5615275
    [No Abstract]   [Full Text] [Related]  

  • 5. [Relationship between the formulation of a tablet and liberation of the active substance].
    Alexis MJ; Baudon MP; Delatre ML; de Mecheleer A; Jehotte MJ; Leduc MP; Leloup MJ; Mathieu MJ; Moran I; Roland MM; Stein J
    J Pharm Belg; 1971; 26(3):252-71. PubMed ID: 5155353
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on flufenamic acid capsules and tablets.
    Akbuğa J; Gülhan S; Bayraktar-Alpmen G
    Pharmazie; 1983 Jul; 38(7):478-80. PubMed ID: 6634915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biopharmacy and pharmacopoeias].
    Mirimanoff A
    Pharm Acta Helv; 1971 Mar; 46(3):129-33. PubMed ID: 5550116
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro comparison of the beaker, the rotating-basket and the column dissolution-rate methods.
    Bathe RV; Häfliger O; Langenbucher F; Schönleber D
    Pharm Acta Helv; 1975; 50(1-2):3-10. PubMed ID: 1114160
    [No Abstract]   [Full Text] [Related]  

  • 9. Absorption enhancement, mechanistic and toxicity studies of medium chain fatty acids, cyclodextrins and bile salts as peroral absorption enhancers.
    Sharma P; Varma MV; Chawla HP; Panchagnula R
    Farmaco; 2005; 60(11-12):884-93. PubMed ID: 16226752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A disintegration test for evaluation of drug availability from tablets and capsules.
    Sandell E; Eriksson K; Mellström G
    Acta Pharm Suec; 1970 Nov; 7(5):559-66. PubMed ID: 5275191
    [No Abstract]   [Full Text] [Related]  

  • 11. [Biologic availability of various formulas of nitrofurantoin in tablets].
    Frigerio G; Venier A
    Boll Chim Farm; 1973; 112(6):416-21. PubMed ID: 4767643
    [No Abstract]   [Full Text] [Related]  

  • 12. The bioavailability of flufenamic acid from aluminum flufenamate tablet and flufenamic acid capsule, and the influence of food and aluminum hydroxide gel.
    Kaniwa N; Ogata H; Aoyagi N; Ejima A
    J Pharmacobiodyn; 1982 Mar; 5(3):187-92. PubMed ID: 7097486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Approach to the technologic and biopharmaceutic evaluation of dermatological preparations].
    Curcio L; Rigamonti S
    Boll Chim Farm; 1971 Aug; 110(8):421-7. PubMed ID: 5137980
    [No Abstract]   [Full Text] [Related]  

  • 14. [Optimization of the technology and a biopharmaceutic study of mefenamic acid suppositories].
    Golovkin VA; Lukash EP; Fadeicheva AG; Groshovyĭ TA; Mokhort NA
    Farmatsiia; 1978; 27(4):16-9. PubMed ID: 689174
    [No Abstract]   [Full Text] [Related]  

  • 15. Biopharmaceutical aspects of the design of steroidal dosage forms.
    Short MP; Rhodes CT
    Pharmazie; 1973 Aug; 28(8):509-13. PubMed ID: 4593892
    [No Abstract]   [Full Text] [Related]  

  • 16. On the characteristics of diluents for direct compression.
    Colombo P; Conte U; Carmella C; Cocchi GA; Catellani P; La Manna A
    Boll Chim Farm; 1976 Aug; 115(8):585-95. PubMed ID: 1016614
    [No Abstract]   [Full Text] [Related]  

  • 17. [Physiolical availability of medicinal agents in tablets and appraisal of their quality tests].
    Mikhaĭlova GS
    Farmatsiia; 1974; 23(1):80-3. PubMed ID: 4817322
    [No Abstract]   [Full Text] [Related]  

  • 18. Frosta: a new technology for making fast-melting tablets.
    Jeong SH; Fu Y; Park K
    Expert Opin Drug Deliv; 2005 Nov; 2(6):1107-16. PubMed ID: 16296813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Polyene antibiotic solubilization by bile acid salts in aqueous solutions].
    Etingova NI
    Antibiotiki; 1981 Jun; 26(6):414-9. PubMed ID: 7271250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro dissolution studies of dexamethasone tablets].
    Sánchez-Morcillo J; Cerezo A; Suñé JM
    Boll Chim Farm; 1975 Aug; 114(8):457-67. PubMed ID: 1182064
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.